The translational regulation of ferritin expression currently represents the only well characterized example for eukaryotic translational control by high affinity interactions between a specific cytoplasmic protein, iron regulatory factor [IRF], and an mRNAbinding site, the iron-responsive element [IRE], located in the 5' untranslated region [UTR] of ferritin mRNAs. To elucidate whether IRE/IRF may represent the first physiological example of a more general mechanism for mRNA-specific translational control, high affinity RNA-binding sites for the bacteriophage MS2 coat protein or the spliceosomal protein U1A were introduced into the 5' UTR of capped chloramphenicol acetyltransferase [CAT] transcripts. In the absence of these RNA-binding proteins, CAT mRNA was efficiently translated. Addition of purified MS2 coat protein or U1A caused a specific, dose-dependent repression of CAT biosynthesis in rabbit reticulocyte and wheat germ in vitro translation systems. The translational blockage imposed by the RNA/protein complex was reversible and did not alter the stability of the repressed mRNAs. Translational repression caused by binding of U1A or MS2 proteins to their target mRNAs is shown to be position-dependent in vitro. Thus, mRNA/protein complexes without an a priori role in eukaryotic mRNA translation function as translational effectors with characteristics resembling those of IRE/IRF.
INTRODUCTION
The contribution of translational regulation to the overall control of gene expression is increasingly recognized. The translation of the vast majority of cellular mRNAs is initiated by a multistep process. The translation apparatus makes first contact with the mRNA at its 5' terminus. This is followed by scanning of the 43S pre-initiation complex, containing the 40S small ribosomal subunit, along the 5' UTR in a 3' direction. Finally, the 60S ribosomal subunit joins the pre-initiation complex at the initiator AUG codon and polypeptide synthesis begins (1) (2) (3) .
Translational control can either be global (i.e. a change in the overall rate of protein biosynthesis) or highly specific for a single (or a small group of) mRNA (1) .
The mRNAs encoding the transcriptional activator GCN4 in Saccharomyces cerevisiae and the iron storage protein ferritin in many multicellular eukaryotic organisms have served as biological model systems for the analysis of translational regulation of specific mRNAs (4) (5) (6) (7) (8) . The mechanisms for translational regulation of the two systems are profoundly different. Regulation of GCN4 expression is achieved by a scanning/re-initiation mechanism (4, 5) . In contrast to GCN4, ferritin mRNAs are translationally controlled by a specific high affinity mRNA/protein complex (6) (7) (8) . The interaction between an iron-responsive element (IRE) contained in the 5' UTR of ferritin mRNAs and a specific cytoplasmic binding protein, iron regulatory factor or 'IRF' (9) [also referred to as IRE-BP (6), FRP (10), or P90 (11) ], represses ferritin mRNA translation in vivo and in vitro (10, (12) (13) (14) . Efficient translational repression via IRE/IRF occurs only if the IRE is located in proximity of the 5' end of the mRNA (14, 15) . Regulation of ferritin translation is mediated by the dependence of the RNA-binding activity of IRF on the cellular iron level (16) (17) (18) (19) . While both systems have shed considerable light on potential mechanisms for translational regulation, analysis of additional examples would be required before general principles for translational control in eukaryotic cells could be established.
In prokaryotes, several mRNAs have been found to be subject to translational control via reversible complexes between the initiator region of the mRNA and specific regulatory binding proteins (20) . At first glance, these examples resemble the regulation of ferritin translation by IRE/IRF, but fundamental differences in the translation initiation pathways between prokaryotic and eukaryotic cells prohibit mechanistic extrapolations. Two alternatives can currently be envisaged for IRF function as a translational repressor. IRF binding to the ferritin IRE could be necessary to recruite a regulatory enzymatic activity to the mRNA or to alter a critical structural feature of the transcript. Alternatively, a high affinity IRE/IRF complex could sterically block a critical step in the initiation pathway. : To whom correspondence should be addressed While a modulating effect of IRF-binding on ferritin mRNA structure has been demonstrated in vitro (11) , no experimental data exist to assess the sterical model.
From these considerations of the ferritin system, the following hypothetical model for cis/trans translational regulation of a specific mRNA was deduced. Transcripts which are efficiently translated per se could harbor a high affinity protein binding site in their 5' UTR. Signal-mediated activation of a specific binding protein would induce the formation of an mRN A/protein complex which represses translation initiation. Reduction of the signal that stimulates binding results in dissociation of this complex and restores efficient mRNA translation. In this report, we test the basic premises of such a model: I) that an efficiently translated mRNA can be specifically repressed by high affinity binding of a protein to a recognition site in the 5' UTR of the transcript; II) that the degree of repression is determined by the molar ratio of mRNA to active repressor; IU) that repression leaves the mRNA structurally and functionally intact. The removal of the repressor should therefore restore translation.
The binding protein/RNA recognition sites that were chosen to evaluate the model fulfilled the following criteria: (a) the RNA recognition site is small, well defined, and point mutations with reduced protein-binding affinity have been identified; (b) the RNA-binding protein can be highly purified from non-eukaryotic sources to exclude possible ambiguities arising from potentially co-purifying eukaryotic translational effectors; (c) the affinity of the protein for the RNA-binding site approaches that of IRF for IRE; (d) the protein itself is not involved in eukaryotic translation. All of these requirements appear to be fulfilled by the bacteriophage MS2 coat protein and its binding site on the MS2 replicase mRNA (21 -23) as well as by the spliceosomal protein Ul A and its binding motif in hairpin II of Ul snRNA (24) (25) (26) . Biologically, the bacteriophage MS2 coat protein has a dual function: it is a structural component of the phage coat, and it contributes to the control of the viral infection cycle by acting as a prokaryotic translational repressor of the phage replicase mRNA (23) . The precise biological role of U1A is not yet completely understood, but its critical contribution to the assembly of a functional splicing apparatus (27, 28) is evident from the severe reduction in pre-mRNA splicing induced by a mutation of the U1A binding site in Xenopus laevis UlsnRNA (29) .
We demonstrate that U1A and MS2 coat protein can adopt a function as eukaryotic translational repressors. We further establish that this function depends on the position of the mRN A/protein complex within the 5' UTR of the transcript.
MATERIAL AND METHODS

Construction of recombinant plasmids
All indicator constructs are derived from the vector pGEM-3Zf(-) (Pharmacia, Uppsala, Sweden), which contains T7 and SP6 promoters. For the construction of the parental CAT vector, the CAT GenBlock (Pharmacia) was blunt-ended and inserted into the HincII site of pGEM-3Zf(-) such that transcription with T7RNA polymerase generates CAT mRNA (T7CAT). Pairs of complementary oligodeoxyribonucleotides corresponding to the protein-binding sequences ('target', Fig. 1 ) were annealed, phosphorylated and ligated into 5' BamHI/3'XbaI of T7CAT to generate UlAwtCAT, UlAmutCAT, MSC-CAT, MSCU-CAT, and MSA-CAT. The plasmids UlAus-CAT, UlAsls-CAT, MSCus-CAT, MSCsls-CAT, MSCUus-CAT and  MSCUsls-CAT, respectively, carry insertions in the unique   BamHI sites of UlAwtCAT, MSC-CAT or MSCU-CAT with  the following sequence: 5' GGATCCCTCT CGAGTTCGAA  GTTAACGATA TCGGATCC 3' for UlAusCAT, MSCus-CAT  and MSCUus-CAT, 5' GGATCCCTCT CGAGTGTTCT  TTGTCAAGGG ACCTTGAGGG ATCC 3' for UlAslsCAT, MSCsls-CAT and MSCUsls-CAT. The correct nucleotide sequences of the insertions of the resultant plasmids were confirmed by direct double-stranded DNA sequencing (Sequenase, United States Biochemicals, Ohio, USA). The plasmid utilized for transcription of NOP1 mRNA was generated by insertion of the full length cDNA (30) into pBluescript II SK and is a kind gift from Ulf Nehrbass (EMBL).
In vitro transcription
Capped mRNAs for in vitro translations were transcribed from HindHI-linearized CAT or BamHI-linearized NOP1 templates in 20 fi\ reactions containing: lmM ATP, CTP, UTP, 10 mM DTT, 1 U Inhibit Ace (5Prime-3Prime, Pennsylvania, USA), 7mM 7 mGpppG, lxtranscription buffer and 60 U of T7 RNApolymerase (Stratagene, La Jolla, USA). After 5 min at 37°C, GTP was added to a final concentration of lmM for an additional 60 min. RNA was purified by phenol and chloroform/isoamylalcohol (24:1) extractions after DNase treatment, two cycles through Sephadex G-50 columns to remove 7 mGpppG, and ethanol precipitation. The capping efficiency was determined to exceed 95% by the method of Dasso and Jakson (31) .
Short RNA competitor transcripts were generated as described by Milligan et at. (32) . The DNA template for the Ul A-binding site was 5' GGGCCGGGGA GTGCAATCCG GCCCTATAGT GAGTCGTATT A 3', the template for the non-specific stemloop competitor was 5' GGGTACGACC AAGTTCGTGA CAACTTCTCT ACCCTATAGT GAGTCGTATT A 3'. Transcription templates and in vitro transcripts were gel-purified and dissolved in diethylpyrocarbonate (DEPC)-treated H 2 O.
Purification of proteins MS2 coat protein was purified as described by Sugiyama et al. (33) with some modifications from bacteriophage MS2 (kindly provided by Dr. Jan van Duin, Leiden, Netherlands). The phage suspension was added to 2 vol. of glacial acetic acid (4°C) and was incubated on ice for 60 min with occasional vortexing. Nucleic acids were removed by centrifugation at 10.000 rpm in an Eppendorf minifuge for 15 min at 4°C. The supernatant was transferred to a fresh tube and centrifugation was repeated. The supernatant was diluted with H 2 O (protein cone. <2 mg/ml) and dialyzed at 4°C for 16 hrs against 3 changes of 1 mM acetic acid, pH 3.2. DTT was added to a final concentration of 1 mM prior to storage at 4°C.
Recombinant human U1A was overexpressed in E.coli using a T7RNA polymerase-based expression system (34) . Two liters of bacterial culture were washed in PBS and approx. 9 g of cells were dissolved in 50 ml of lysis buffer (20 mM Hepes, pH7.2, 100 mM NaCl, 1 mM EDTA, 1 mM DTT, 1 mM PMSF, 0.1 mM benzamidine, 0.5% NP-40, 1 Atg/ml leupeptine, 1 jig/ml pepstatin) and sonicated for 15 cycles (40W) of 30 sec. (Branson Sonic Power Company, Danbury, USA) on ice. The lysate was cleared by centrifugation, 1 % (w/w) protamine sulfate was added to the supernatant and incubated for 30 min on ice. Nucleic acids were removed by centrifugation as before. The supernatant was equilibrated with ammonium sulfate to a final concentration of 1.3 M, and pre-purified by subsequent phenylsepharose CL-4b (Pharmacia) and phosphate cellulose PI 1 (Whatman, Maidstone, Great Britain) chromatography. The final purification was achieved by FPLC using a Mono-S column. The purified protein was stored in 20mM Hepes, pH 7.2, lmM DTT at -20°C. Before usage, the proteins were incubated with Inhibit Ace (1U/20 /xl) for 30 min at room temperature.
In vitro translation and gel electrophoresis
Capped CAT and NOPl mRNAs were translated in rabbit reticulocyte lysate (RRL) or wheat germ extract (WGE) according to the manufacturer's protocol (Promega, Madison, USA). 2 ng of NOPl and 2 ng of CAT mRNA were translated in 10 fil reactions for U1A repression experiments shown in Fig.2 , whereas 1 ng NOPl and 0.5 ng CAT mRNA were used for the MS2 coat protein experiments in Fig.3 S] methionine, and 5 /tl of wheat germ extract. U1A and MS2 coat protein were diluted in their respective storage buffers and added to the master mix containing the mRNAs. Storage buffer instead of protein was used for negative controls. After incubation for 15 min at 4°C to allow RNA/protein complex formation, the in vitro translation reaction was started at the adequate temperature. Translation products were analyzed by SDSpolyacrylamide gel electrophoresis (SDS-PAGE) (15% polyacrylamide). Gels were fixed in 20% methanol/10% acetic acid, treated with Entensify (NEN, Boston, USA), dried, and exposed.
Northern blot analysis of in vitro translated mRNAs
The RRL in vitro translation for RNA extraction and Northern Blotting was performed as a 30 /il reaction. 8 ng each of NOPl and UlAwtCAT or UlAmutCAT transcripts and a 600-fold molar excess of U1A (or buffer) were added. 11 pi were mock translated on ice, the remaining 19 jtl incubated at 30°C. After 60 min, 11 fd were saved for RNA extraction, the rest was used for SDS-PAGE analysis. 5 ng bacterial tRNA were added to mock-and post-translation samples as a carrier. The mixture was extracted once with phenol and once with chloroform/isoamylalcohol (24:1). The extracted samples were ethanol precipitated, the pellet resuspended in a formamide/formaldehyde RNA loading buffer and separated on 1.2% formaldehyde/agarose gels. Northern Blots were probed simultaneously with NOPl and CAT probes.
Translation analysis of re-extracted transcripts
The primary in vitro translation was carried out in RRL as a 75 fi\ reaction with 40 ng of NOPl and UlAwtCAT transcripts and a 250-fold molar excess of U1A (or storage buffer). After translation, a 7.5 /d aliquot was analyzed by SDS-PAGE. 150 ti\ of buffer (50mM Tris-HCl, pH 7.4; 5 mM EDTA; 1.5% SDS; 300mM NaCl; 1.5 mg/ml Proteinase K) were added to the remainder and incubated at 37°C for 30 min. After two phenol extractions and one chloroform/isoamylalcohol extraction for 20 min at 37°C, RNA was ethanol precipitated from the aqueous phase using 20 ng glycogen as a carrier. The pellet was washed twice with cold 80% ethanol, air dried and resuspended in 15 /il of DEPC-treated water. 3 /d of this sample were translated in RRL and WGE systems as described, and analyzed by SDS-PAGE. In rabbit reticulocyte lysate (RRL) NOPl, UlAwtCAT and UlAmutCAT mRNAs were translated with similar efficiencies under conditions where mRNA is limiting and protein biosynthesis is proportional to the amount of translatable mRNA ( Fig.2A , compare lanes 2,3 and 6). When a 450-fold or 900-fold molar excess of recombinant U1A protein purified from E.coli was added to reactions containing NOPl and UlAwtCAT mRNA, only CAT biosynthesis decreased in a concentrationdependent fashion; the translation of the internal control transcript, NOPl, remained unchanged ( Fig.2A, lanes 3-5) . By contrast, UlAmutCAT mRNA translation was insensitive to U1A addition ( Fig.2A, lanes 6-8) , demonstrating specificity of repression and strongly suggesting that high affinity binding of the protein to the mRNA is required. To confirm that the repression of UlAwtCAT mRNA translation by U1A in RRL reflected a general feature of eukaryotic translation, the same experiment was repeated in wheat germ extract (WGE) (Fig.2B) . NOPl mRNA was intrinsically less well translated than UlAwtCAT and UlAmutCAT mRNA, probably reflecting either the lower efficiency of WGE in supporting synthesis of larger polypeptides or different optima of cation concentrations of the two transcripts (35) . However, the outcome of the WGE experiment confirmed the specific translational repression by U1A. A quantitative analysis of the data shown in Fig. 2 is provided in Table 1 .
RESULTS
Cis
Targeted translational repression by the bacteriophage MS2 coat protein
To evaluate the general validity of repression by RNA/protein complex formation, U1A protein and its binding site were replaced by the bacteriophage MS2 system. In addition to the wild type RNA-binding sequence (relative Ka 1.0), UhJenbeck and co-workers have identified a U to A point mutation in the loop that drastically reduces MS2 coat protein binding (rel. Ka 0.01) and a U to C exchange that strongly increases MS2 affinity above wild type levels (rel. Kj, 52.0) (21,23). These three target sites were inserted into the CAT reporter transcript to create MSU-CAT, MSA-CAT and MSC-CAT (Fig. 1) . MSCU-CAT is a fourth construct which harbors two MS2 binding sites that display co-operative MS2 coat protein binding (22) . Surprisingly, translation of the wild type construct MSU-CAT was not repressed by addition of coat protein purified from the coliphage MS2 at up to 80000-fold molar excess in both RRL and WGE (data not shown). Possibly, RNA sequences flanking the MS2 coat protein binding site might affect the secondary structure of the transcript in such a way that MS2 coat protein binding to its cognate RNA hairpin structure was impaired. However, we reasoned that the affinity of MS2 coat protein for the wild type binding site (Kj 1-7 nM; (36)) may be insufficient to convey translational repression in a eukaryotic system. We proceeded to test this assumption with MSC-CAT and MSCU-CAT which permit a higher affinity interaction with MS2 coat protein than MSU-CAT, using MSA-CAT as a negative and NOPl as an internal control. NOPl biosynthesis and MSA-CAT mRNA translation were not affected by the presence of the MS2 coat protein (Fig.3A and B, lanes 16-18) . As predicted, MS2 coat protein addition to RRL (Fig.3A) and WGE (Fig.3B) imposed a concentration-dependent blockage to MSC-CAT (lanes 3-8) and MSCU-CAT (lanes 9-15) mRNA translation. The quantitative analysis of these results revealed no significant differences between the responses of MSC-CAT and MSCU-CAT mRNA to coat protein titration ( Table 1 ). The data summarized in Table 1 for eukaryotic translational repressors (at least in vitro) which exceeds the affinity of U1A for the UlAmutCAT and of MS2 coat protein for MSU-CAT binding sites.
Translationally repressed transcripts are not degraded
The specific reduction in CAT biosynthesis imposed by protein binding could result from functionally dormant mRNA (translational repression in a strict sense) or from targeted degradation of the translation template. To distinguish between these two possibilities, a repression experiment with the U1A system was performed where mRNA was extracted from aliquots and increasing repressor protein concentrations support this model (Table 1) . We proceeded to analyze this prediction by increasing the number of specific binding sites (while keeping the protein concentration constant) which should rescue translation of the target mRNA. NOPl and UlAwtCAT mRNAs were incubated with an excess of oligoribonucleotide that acts as a U1A binding site (Fig.5A , 'specific competitor') or with an unrelated stemloop RNA transcript ('non-specific competitor') prior to addition of U1A protein. The 600-fold molar excess of U1A over mRNA repressed CAT biosynthesis in RRL (compare lanes 3 and 4) . Inclusion of an equimolar amount or a 4-fold molar excess of non-specific competitor RNA over U1A protein had no effect on CAT (or NOPl) translation (lanes 5 and 6), whereas the same quantities of specific competitor completely (lane 7) or partially (lane 8) alleviated repression of UlAwtCAT mRNA translation. In the absence of repressor protein, the competitors had no effect on UlAwtCAT mRNA translation Ganes 9-12). Consequently, the ratios rather than the absolute concentrations of mRNA and repressor protein determine the translational efficiency of the mRNA in the presence of a specific mRNA-binding protein.
When adding specific competitor RNA 7.5 min (Fig.5B) . Addition of the competitor transcripts had no effect on unrepressed UlAwtCAT (lanes 1 -3) or NOPl mRNAs. These results suggest that CAT mRNA translation can occur after the effective repressor concentration has decreased and indicate that a de-repressed transcript can function as an efficient template for translation (see below).
Translation of attenuated mRNA is restored by repressor removal
The final premise of our model is that repressed mRNA can be actively translated after the repressor has dissociated from the transcript. Conceivably, protein binding could induce a modification of the mRNA (37) which rendered it permanently non-translatable. The observation that the translation of repressed UlAwtCAT mRNA could be relieved by delayed addition of specific competitor transcripts (Fig.5B) suggested that efficient translation could occur after repressor dissociation. However, it could be argued that the mRNA was inactivated after prolonged (> 15 min) repression. We approached this question by translation of duplicate samples of UlAwtCAT (and NOPl) mRNA in RRL in the presence or absence of U1A protein (Fig.6A) and isolation of total RNA from this primary reaction by proteinase K treatment, phenol/chloroform extraction and ethanol precipitation. Subsequently, re-extracted RNA was analyzed by translation in RRL and WGE. Unfortunately, in vitro translation of re-extracted RNA repeatedly gave rise to high background levels in both RRL and WGE. However, it is clearly apparent that repressed (Fig.6A, lanes 3a/b) and non-repressed ( velocities of globin translated from endogenous message and CAT protein (data not shown). We conclude that removal of the repressor protein from the mRNA restores translation to a level identical to that of a primarily unrepressed transcript.
Translational repression by mRNA/protein complexes is position-dependent
The position of the IRE within the 5' UTR of an mRNA has been identified as a critical cz's-determinant for function of IRE/IRF in vivo, since introduction of spacer sequences between the cap structure and the IRE results in a profound reduction of translational repression by IRF-binding (14, 15) . Having established that the spliceosomal protein U1A and the bacteriophage MS2 coat protein could adopt functions as mRNAspecific translational repressors, we examined whether these experimentally created in vitro systems displayed the same position effect. Two different spacer sequences, one of which is predicted to form a stem-loop structure ('sis', Fig.7 ) and the other to be relatively unstructured ('us', Fig.7 ), were introduced immediately 5' of the protein binding sites of UlAwtCAT (Fig.7A and Table 2 ), MSCU-CAT ( Fig.7B and Table 2 ), and MSC-CAT (Table 2) to generate the six constructs UlAusCAT, UlAslsCAT, MSCUus-CAT, MSCUsls-CAT, MSCus-CAT and MSCsls-CAT. Addition of 800-fold molar excess of the respective repressor proteins to the three spacer-less CAT mRNAs reduces translation to <34% (Fig.7A/B and Table 2 ). The 32 nucleotide long 'us' and the 38 nucleotide 'sis' insertions restore translation in all six different spacer-containing transcripts, generally (in 5/6 cases) resulting in a 2-to 3-fold stimulation (Table 2 ). Thus, for three different protein-binding sites and two spacers that vary in primary sequence and predicted secondary structures, similar effects were observed. We conclude that translational repression by mRNA/UlA or/MS2 coat protein complexes is positiondependent and we suggest that position dependence is a general (although perhaps not universal) characteristic of translational repression by high affinity RNA/protein complexes in the 5' UTR. Whether or not translational repression by IRE/IRF and the systems described here is mechanistically identical remains however to be elucidated.
DISCUSSION
The concept of translational regulation in eukaryotes by reversible mRNA/protein interactions was first entertained more than 20 years ago. The hypothesis was based on the observation that a pool of nonpolysomal, protein-associated mRNA existed in the cytoplasm (38, 39) . These messenger ribonucleoprotein complexes were referred to as 'informosomes' (39) . At the time, Spirin made the farsighted prediction of 'a concrete form of protein synthesis regulation at the translational level' where 'the protein of informosomes can be considered as a regulatory protein capable of specifically binding and blocking definite mRNAs from involvement in polyribosomes and loosening the block at some intracellular signal ' (1969) . At present, one well defined biological example, the control of ferritin and erythroid 5-aminolevulinate synthase mRNA translation by IRE/IRF, fulfills all the criteria of Spirin's proposal (6) (7) (8) .
These early concepts and the analysis of the ferritin system led to the formulation of a general model for translational regulation by mRNA/protein complex formation which is depicted in Fig. 8 . In this study, the basic premises of this model were evaluated. We selected rabbit reticulocyte-and wheat germderived in vitro translation systems for their amply documented ability to faithfully reflect most aspects of eukaryotic translation initiation in vivo (31, 35) . Furthermore, both systems have been shown to accurately reproduce the translational repression of ferritin mRNA by IRF in vivo (10, 13) , and even be able to discriminate between functionally critical IRE point mutations (Gray et ai, manuscript in preparation). In contrast to cell transfection approaches, facile, well controlled variations in the mRNA/protein ratios can be achieved in vitro using defined transcripts and purified proteins.
Our results demonstrate that high affinity binding of a bacteriophage or a spliceosomal protein to a site 31 nucleotides downstream from the cap structure in the 5'UTR of an mRNA represses its translation. Common denominators of the two repressors, the bacteriophage MS2 coat protein (14 kDa) and the UlsnRNP-specific protein U1A (34 kDa), are their capacity to engage in an RNA/protein interaction with defined hairpin structure binding sites, and their lack of involvement in eukaryotic mRNA translation (although MS2 coat protein is a prakaryotic translational repressor). The Kj for the binding of active IRF to an IRE has been determined to be 0.01 -0.09 nM . This compares to estimates varying from 0.02-30 nM for the interaction of U1A with its physiological binding site (40-42; Boelens and Venrooij, personal communication) and 1-7 nM for the binding between MS2 coat protein and its cognate RNA (36) . The Kj for the higher affinity binding of MS2 coat protein to the MSC (or MSCU)-CAT mutations or the lower affinity binding of U1A protein to UlAmutCAT are not available. Considering that MSU-CAT mRNA was (in contrast to MSC-CAT) not translationally repressed by MS2 coat protein, we tentatively suggest that the Kj for the interaction between a putative repressor protein with the mRNA target site likely has to be < 1 nM. This suggestion is also consistent with the finding that the translationally 'inactive' form of IRF binds to the ferritin IRE with a Kj of approx. 2-5 nM (18) .
The affinity of the protein for its binding site and the ratio of repressor protein to targeted mRNA are likely to represent interdependent determinants of the translational effect of the cis/trans interaction. We noticed that a relatively large molar excess of protein over mRNA was necessary to achieve complete translational repression in vitro. However, the specific RNAbinding activities of the Ul A and MS2 coat protein preparations are not known and may bias the results towards underestimating the repressor effect. U1A and MS2 repressors require approximately 10-fold higher concentrations than comparable in vitro translation systems with the IRE/IRF (13; Gray et al., manuscript in preparation). This quantitative difference supports our suggestion of the interdependent nature of repressor protein concentration and binding site affinity, considering the higher binding affinity of active IRF to its mRNA target (18, 36, 40, 41, 43 ; Boelens and van Venrooij, personal communication). Eukaryotic in vivo models to examine the effects of U1A and MS2 are currently being established. In contrast to the in vitro systems described here, in vivo systems have to be controlled for relative lack of effective repressor protein arising from internal competition (from Ul snRNA), protein instability or for possible spacial dissociation of the repressor protein from the target mRNA .
The in vitro systems described here should permit a more precise definition of minimal affinity thresholds for an RNA/repressor protein interaction and are suitable to identify possible region(s) outside of the 5' UTR of an mRNA that are susceptible to translational attenuation by a binding protein as well. At present, we have to content ourselves with speculations concerning the precise molecular mechanism by which an mRNA binding protein inhibits translation. Considering the postulates of the 'scanning hypothesis' (2, 3) , it seems to be a fair assumption that one of the steps necessary for the pre-initiation complex to reach the AUG translation start codon is blocked by the specific mRNP. The affinity threshold for the repressor complex then likely reflects the ability of the initiation apparatus to dissociate this complex. Similarly, RNA secondary structures that exceed a minimal stability have been demonstrated to impede translation initiation (44) (45) (46) . The biochemical accessibility of the systems described in this report together with the availability of antibodies against the U1A and MS2 coat protein repressors should greatly facilitate analyses of the molecular mechanism of translational repression by an mRNA/protein complex.
How might translational repression by RNA/protein complex formation by utilized physiologically to regulate translation? We envision at least three different scenarios. First, the RNA-binding activity of the repressor protein could be controlled in response to a regulatory signal. This scenario is exemplified by the regulation of IRF by iron. Second, the expression of the repressor could be regulated in a cell type, developmental stage or signaldependent manner. Third, the expression of the repressor were constitutive and the proposed mechanism served as a means for autoregulatory negative feedback control by binding of 'excess' protein to a site located in the 5' UTR of its own mRNA. Such a mechanism would seem particularly well suited to adjust the relative amounts of RNA-binding proteins that are constituents of multi-protein RNPs such as the spliceosome, the ribosome, the signal recognition particle and others.
Cw-regulatory sequences which might serve as protein binding sites have been identified within several translationally regulated mRNAs (47) (48) (49) (50) (51) (52) . We hope that the demonstration that high affinity (m)RNA-binding suffices to qualify a protein as a potential translational repressor may also encourage intensive searches for as yet undiscovered examples of translational attenuators. In bacteria, the majority of proteins known to act as translational repressors have additional independent functions (53) . The translational repressor IRF may be identical with the cytoplasmic form of the enzyme aconitase (19, (54) (55) (56) (57) . Other enzymes or structural proteins may surprise with an additional role as a translational repressor by high affinity mRNA binding (58) .
